Back
Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
20.95
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Catalyst Pharmaceuticals Price Quote
$20.95
-0.20 (-0.95%)
(Updated: November 21, 2024 at 11:45 AM ET)
Catalyst Pharmaceuticals Key Stats
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Day range:
$21.05 - $21.63
52-week range:
$13.00 - $24.27
Dividend yield:
0%
P/E ratio:
33.05
P/S ratio:
5.51
P/B ratio:
3.76%
Volume:
947.3K
Avg. volume:
978.1K
1-year change:
54.27%
Market cap:
$2.5B
Revenue:
$398.2M
EPS:
$1.18
How Much Does Catalyst Pharmaceuticals Make?
-
How Much Are Catalyst Pharmaceuticals's Sales Annually?
CPRX Revenues are $398.2M -
How Much Profit Does Catalyst Pharmaceuticals's Make A Year?
CPRX net income is $71.4M
Is Catalyst Pharmaceuticals Growing As A Company?
-
What Is Catalyst Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.25% -
What Is Catalyst Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Catalyst Pharmaceuticals Stock Price Performance
-
Did Catalyst Pharmaceuticals Stock Go Up Last Month?
Catalyst Pharmaceuticals share price went down by -0.42% last month -
Did CPRX's Share Price Rise Over The Last Year?
CPRX share price rose by 54.27% over the past 1 year
What Is Catalyst Pharmaceuticals 52-Week High & Low?
-
What Is Catalyst Pharmaceuticals’s 52-Week High Share Price?
Catalyst Pharmaceuticals has traded as high as $24.27 over the past 52 weeks -
What Is Catalyst Pharmaceuticals’s 52-Week Low Share Price?
Catalyst Pharmaceuticals has traded as low as $13.00 over the past 52 weeks
Catalyst Pharmaceuticals Price To Free Cash Flow
-
Is Catalyst Pharmaceuticals Stock Overvalued?
Catalyst Pharmaceuticals is trading at a price to free cash flow ratio of 11.43 -
Is Catalyst Pharmaceuticals Stock Undervalued?
Catalyst Pharmaceuticals EV to Free Cash Flow ratio is 9.20 -
What Is Catalyst Pharmaceuticals’s Price Earnings Growth Ratio?
CPRX PEG ratio is 0.14 -
Is Catalyst Pharmaceuticals Trading At A Premium To Earnings?
Catalyst Pharmaceuticals EV to EBIT ratio is 11.73
Is It Risky To Buy Catalyst Pharmaceuticals?
-
How Much Debt Does Catalyst Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Catalyst Pharmaceuticals Have?
Cash and short term investments quarterly total is $442.3M -
What Is Catalyst Pharmaceuticals’s Book Value Per Share?
Book value per share is 5.54
Is Catalyst Pharmaceuticals Cash Flow Positive?
-
What Is CPRX Cash Flow From Operations?
Cash flow from operations (TTM) is $224.6M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $135.6M -
What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$38.8M
Catalyst Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
CPRX return on invested capital is 27.81% -
What Is Catalyst Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 23.73% -
What Is CPRX Return On Equity?
ROE is a measure of profitability and is 27.81%
Catalyst Pharmaceuticals Earnings Date & Stock Price
-
What Is Catalyst Pharmaceuticals's Stock Price Today?
A single share of CPRX can be purchased today for 21.15 -
What Is Catalyst Pharmaceuticals’s Stock Symbol?
Catalyst Pharmaceuticals trades on the nasdaq under the ticker symbol: CPRX -
When Is Catalyst Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Catalyst Pharmaceuticals is scheduled on February 28, 2025 -
When Is CPRX's next ex-dividend date?
Catalyst Pharmaceuticals's next ex-dividend date is May 30, 2020 -
How To Buy Catalyst Pharmaceuticals Stock?
You can buy Catalyst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Catalyst Pharmaceuticals Competitors
-
Who Are Catalyst Pharmaceuticals's Competitors?
Below is a list of companies who compete with Catalyst Pharmaceuticals or are related in some way:
Catalyst Pharmaceuticals Dividend Yield
-
What Is CPRX Dividend Yield?
Catalyst Pharmaceuticals’s dividend yield currently is 0% -
What Is Catalyst Pharmaceuticals’s Payout Ratio?
Catalyst Pharmaceuticals’s payout ratio is 0% -
When Did Catalyst Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Catalyst Pharmaceuticals’s Dividend Per Share?
Catalyst Pharmaceuticals pays a dividend of $0.00 per share
Catalyst Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 12.71% |
| Revenue: | 25.33% | 4.27% |
Analyst Recommendations
| Buy Recommendations: | 5 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 31.86 |
| Upside from Last Price: | 50.62% |